151 related articles for article (PubMed ID: 16671337)
1. T1198C polymorphism of the angiotensinogen gene and antihypertensive response to angiotensin-converting enzyme inhibitors.
Yu H; Lin S; Liu G; Zhang Y; Deng C; Ma W
Hypertens Res; 2005 Dec; 28(12):981-6. PubMed ID: 16671337
[TBL] [Abstract][Full Text] [Related]
2. Intron-2 conversion polymorphism of the aldosterone synthase gene and the antihypertensive response to angiotensin-converting enzyme inhibitors.
Yu H; Lin S; Zhang Y; Liu G
J Hypertens; 2008 Feb; 26(2):251-6. PubMed ID: 18192839
[TBL] [Abstract][Full Text] [Related]
3. [The AGT genotype affects the antihypertensive effects of benazepril].
Yu HM; Lin SG; Zhang YQ; Ma WJ; Liu GZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep; 33(9):819-23. PubMed ID: 16266458
[TBL] [Abstract][Full Text] [Related]
4. Association between angiotensinogen, angiotensin II receptor genes, and blood pressure response to an angiotensin-converting enzyme inhibitor.
Su X; Lee L; Li X; Lv J; Hu Y; Zhan S; Cao W; Mei L; Tang YM; Wang D; Krauss RM; Taylor KD; Rotter JI; Yang H
Circulation; 2007 Feb; 115(6):725-32. PubMed ID: 17261659
[TBL] [Abstract][Full Text] [Related]
5. [The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan].
Zhao C; Wang YY; Xiao ZX; Wang YP; Zhang QY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):428-31. PubMed ID: 17680535
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of the angiotensinogen gene and the outcome of microalbuminuria in essential hypertension: a 3-year follow-up study.
Marin P; Julve R; Chaves FJ; Giner V; Pascual JM; Armengod ME; Redon J
J Hum Hypertens; 2004 Jan; 18(1):25-31. PubMed ID: 14688807
[TBL] [Abstract][Full Text] [Related]
7. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure.
Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH
Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011
[TBL] [Abstract][Full Text] [Related]
8. E112D polymorphism in the prolylcarboxypeptidase gene is associated with blood pressure response to benazepril in Chinese hypertensive patients.
Zhang Y; Hong XM; Xing HX; Li JP; Huo Y; Xu XP
Chin Med J (Engl); 2009 Oct; 122(20):2461-5. PubMed ID: 20079160
[TBL] [Abstract][Full Text] [Related]
9. Relationship between polymorphism of the angiotensin-converting enzyme gene and the response to angiotensin-converting enzyme inhibition in hypertensive patients.
Yu H; Zhang Y; Liu G
Hypertens Res; 2003 Nov; 26(11):881-6. PubMed ID: 14714579
[TBL] [Abstract][Full Text] [Related]
10. A common haplotype on methylenetetrahydrofolate reductase gene modifies the effect of angiotensin-converting enzyme inhibitor on blood pressure in essential hypertension patients--a family-based association study.
Jiang S; Hsu YH; Niu T; Xu X; Xing H; Chen C; Wang X; Zhang Y; Peng S; Xu X
Clin Exp Hypertens; 2005 Aug; 27(6):509-21. PubMed ID: 16081343
[TBL] [Abstract][Full Text] [Related]
11. Effect of renin-angiotensin-aldosterone system gene polymorphisms on blood pressure response to antihypertensive treatment.
Jiang X; Sheng HH; Lin G; Li J; Lu XZ; Cheng YL; Huang J; Xiao HS; Zhan YY
Chin Med J (Engl); 2007 May; 120(9):782-6. PubMed ID: 17531119
[TBL] [Abstract][Full Text] [Related]
12. [The relationship between the variants in 5' upstream core promoter A(-6)G and A(-20)C of angiotensinogen gene and essential hypertension in Kazakans of Xinjiang].
Li NF; Zhou L; Wu WD; Shi Y; Wang XL; Wang J; Li HJ; Zhang DL; Zu H; Ouyang WJ; Bu KL; Zhou KM; Cheng QY; Guli N; Zhu DH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):23-8. PubMed ID: 14767903
[TBL] [Abstract][Full Text] [Related]
13. Associations between CYP11B2 gene polymorphisms and the response to angiotensin-converting enzyme inhibitors.
Yu HM; Lin SG; Liu GZ; Zhang YQ; Ma WJ; Deng CY
Clin Pharmacol Ther; 2006 Jun; 79(6):581-9. PubMed ID: 16765146
[TBL] [Abstract][Full Text] [Related]
14. A single nucleotide polymorphism in the carboxylesterase gene is associated with the responsiveness to imidapril medication and the promoter activity.
Geshi E; Kimura T; Yoshimura M; Suzuki H; Koba S; Sakai T; Saito T; Koga A; Muramatsu M; Katagiri T
Hypertens Res; 2005 Sep; 28(9):719-25. PubMed ID: 16419644
[TBL] [Abstract][Full Text] [Related]
15. Interactions between five candidate genes and antihypertensive drug therapy on blood pressure.
Schelleman H; Stricker BH; Verschuren WM; de Boer A; Kroon AA; de Leeuw PW; Kromhout D; Klungel OH
Pharmacogenomics J; 2006; 6(1):22-6. PubMed ID: 16314886
[TBL] [Abstract][Full Text] [Related]
16. [Demonstration of differences in the effect of 2 antihypertensive agents by self blood pressure measurement: comparison of trandolapril and perindopril].
Bobrie G; Dutrey-Dupagne C; Vaur L; Dubroca I; Elkik F; Chatellier G; Ménard J
Therapie; 1997; 52(3):187-93. PubMed ID: 9366102
[TBL] [Abstract][Full Text] [Related]
17. [Studies of the association between angiotensinogen gene regulation and cytokines in essential hypertension].
Wang AL; Yu YX; Xu Y; Liu P; Chen ZP; Zhang L; Wu JX; Sun GM; Chen S
Yi Chuan Xue Bao; 2003 Oct; 30(10):978-82. PubMed ID: 14669517
[TBL] [Abstract][Full Text] [Related]
18. [Association of alpha-adducin and angiotensin converting enzyme gene polymorphisms with salt-sensitive hypertension and early renal injury].
Lu LH; Chen H; Yu L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):132-5. PubMed ID: 18393230
[TBL] [Abstract][Full Text] [Related]
19. [Effect of CYP11B2 gene -344T/C polymorphism on renin-angiotensin-aldosterone system activity and blood pressure response to hydrochlorothiazide].
Li Y; Yang P; Wu SL; Yuan JX; Wu Y; Zhao DD; Xu S; Zhao LP; Sun MJ; Chu LM; Lu DS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Feb; 29(1):68-71. PubMed ID: 22311496
[TBL] [Abstract][Full Text] [Related]
20. Association of angiotensinogen (M235T) gene polymorphism with blood pressure lowering response to angiotensin converting enzyme inhibitor (Enalapril).
Srivastava K; Chandra S; Bhatia J; Narang R; Saluja D
J Pharm Pharm Sci; 2012; 15(3):399-406. PubMed ID: 22974788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
